期刊文献+

老老年人群急性脑心联合梗死的回顾性分析 被引量:2

The Retrospective Analysis of Senile Elderly Patients with Acute Brain Heart Jointing Infarction
下载PDF
导出
摘要 目的探讨老老年患者急性脑梗死合并急性心肌梗死的发病情况、预后及影响因素。方法回顾分析十年间急性脑梗死住院病例资料,观察老老年组、老年组脑心联合梗死与单一脑梗死临床相关指标。结果老老年脑梗死717例中脑心联合梗死发生率、死亡率(2.09%、53.33%)比普通老年联合梗死组(0.42%、14.29%)更高,差异有统计学意义(P<0.01)。老老年组在男性、上消化道出血、梗死后出血转化、糖尿病、既往心肌梗死史、高脂血症、高血压发生率稍高,但与老年组比较差异无统计学意义(P>0.05),而心房颤动(40.00%)、既往脑卒中史发生率(66.67%)高于老年脑心联合梗死组,差异有统计学意义(P<0.05)。结论老老年组脑心联合梗死预后差,院前加强危险因素的控制措施,住院后采取积极治疗措施可改善结局。 Objective To explore the incidence of senile elderly patients(SEPs) suffering from acute myocardial infarction (AMI) fol- lowing acute ischaemic stroke(AIS)and to analyse prognosis and impact factors. Methods Cases hospitalized with AIS over the past decade were collected and classified into two groups according to the different age and joint infarction. Results 717 cases of SEPs were enrolled. Compared with the control group(0.42%; 14.29%), SEPs had a higher co-morbidity and mortality(2.09%; 53.33 % ). The incidence of male, upper gastrointestinal bleeding, Bleeding after Infarction, Diabetes Mellitus, remote myocardial infarction, Hyperlipidemias and Hypertension were mild higher than the control, but there was no statistical significance( P 〉 0.05). The incidence of atrial fibrillation(40.00 % ), remote ischaemic stroke(66.67 % ) were associated with SEPs joint infarction. Conclu- sions SEPs with joint infarction would have poor Endings. Positive control measures may improve outcome.
出处 《心脑血管病防治》 2012年第6期449-451,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 老老年 脑心联合梗死 危险因素 预后 Senile elderly patients Acute myocardial infarction and acute ischaemic stroke Risk factors Joint infarction
  • 相关文献

参考文献3

二级参考文献243

  • 1Rose G. Detection of high coronary risk. Postffad Med J, 1976, 52: 452-455.
  • 2Wilson PW, D'Agostino RB, Levy D, a al. Prediction of coronary heart disease using risk factor categories. Circulation, 1998, 97: 1837-1847.
  • 3Gnmdy SM, Balady GJ, Criqui MH, et al; Atrmican Heart Associa- tion. Primary prevention of coromry heart disease: guidance from Framingham a statement for healthcare professionals from the AHA Task Force on Risk Reduction. Circulation, 1998, 97: 1876-1887.
  • 4Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002, 360: 7-22.
  • 5National Cholesterol Education Progam (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002, 106: 3143 -3421.
  • 6Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation, 2002, 106: 388-391.
  • 7Mosca L, Benjamin El, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation, 2011, 123: 1243-1262.
  • 8Sacco RL, Kargran DE, Gu Q, et al. Race-ethnicity and determinants of intmcranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study. Stroke, 1995, 26: 14-20.
  • 9D'Agostino RB St, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, 2008, 117: 743-753.
  • 10Dhamoon MS, Elkind MS. Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease. Circulation, 2010, 121:2071-2078.

共引文献1506

同被引文献14

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部